New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions
It also indicates greater Agency scrutiny of such transactions in industries characterized by differentiated products and high levels of R&D spendingÃ¢â‚¬â€such as the high tech and pharmaceutical industries. Janet McDavid & Eric Stock (Hogan Lovells)
When requesting a correction, please mention this item's handle: RePEc:cpi:atchrn:10.2.2010:i=5719. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Lindsay McSweeney)
If references are entirely missing, you can add them using this form.